RPRX has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Repros Therapeutics, Inc.'s quarterly common stock stayed the same from Jun. 2013 ($0.02 Mil) to Sep. 2013 ($0.02 Mil) and stayed the same from Sep. 2013 ($0.02 Mil) to Dec. 2013 ($0.02 Mil).
Repros Therapeutics, Inc.'s annual common stock increased from Dec. 2011 ($0.01 Mil) to Dec. 2012 ($0.02 Mil) and increased from Dec. 2012 ($0.02 Mil) to Dec. 2013 ($0.02 Mil).
Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.
The par value of common stocks is meaningless. It is usually set at an absurdly low number.
* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.
Repros Therapeutics, Inc. Annual Data
Repros Therapeutics, Inc. Quarterly Data